Clinical Trial Search

Primary: Number of Index Participants and Their Household Contacts With SARS-CoV-2 RNA Detection in Nasal Samples Over the Study/Surveillance Period — 98.9; 99.2; 99.1; 98.0…

Primary: Evaluation of Acceptability of Intervention as Measured by Acceptability Questionnaire — 4.47 score on a scale

Primary: SARS-CoV-2 Infection — 4; 2 Participants

Primary: PTSD Symptom Severity — 16.36; 17.10; 15.56; 15.78 score on a scale — p=.77

Primary: Difference in Days Alive and Out of Hospital — 29.5; 29.4 days

Primary: Help Seeking Intention — 7.4; 7.9; 7.3; 8.2 units on a scale — p=0.031

Primary: The Percent of Participants With Tracheal Intubation or Death Prior to Tracheal Intubation — 26.2; 22.2 percentage of participants

Primary: Sensitivity of Detecting SARS-CoV-2 RNA — 31; 0 Participants

Primary: Number of Patients With TEAEs — 3; 4; 3; 1 Participants

Primary: Measure of Daily Stool Frequency for Patients With COVID Treated With Bismuth — 3 bowel movements

Primary: Number of Participants With Problems in Their Health Care Due to COVID-19 Related Isolation — 155 Participants

Primary: Brief Psychiatric Rating Scale (BPRS) — 29.30; 32.80; 30.25 score on a scale

Primary: The Incidence of COVID-2019 Cases. — 259.95 COVID-2019 cases per 1000 person

Primary: Participants Enrolled — 36 Participants

Primary: Motor Balance as Measured by Timed Up and Go (TUG) — 20.57 seconds

Primary: Testing Barriers and Hesitancy — 0.29; 0.24 score on a scale — p=0.09

Primary: Completion of COVID-19 Test — 72; 60 Participants

Primary: Everyday Impairment — 15.65; 15.47; 12.74; 13.23 Scores on a scale

Primary: Proportion of Eligible Participants Who Agree to Participate — 74 Participants

Primary: Number of Participants With National Early Warning Score (NEWS) Change From 3 to 0 — 44; 29 Participants

Primary: COVID-19 Prevention Health Behaviors 1 — 6.0; 6.7; 4.8 score on a scale — p=.26

Primary: Number of Composite Primary End Point (Critical Care Admission, Palliative Discharge When Discharged From Hospital, or Mortality Within the 6 Weeks After Diagnosis of…

Primary: Number of Samples Tested — 3692 samples

Primary: Instrumental Activities of Daily Living and Activities of Daily Living (I/ADL) Score — 3.40; 3.05; 3.50; 3.40 I/ADL Score — p=0.77

Primary: Patient Choosing Telehealth as an Option for Future Care — 523; 43; 36 Participants

Primary: Body Temperature — 98.1 degrees Fahrenheit

Primary: Number of Participants Intubated During Hospitalization — 8; 25 Participants — p=0.297

Primary: Frequency of Any Medically-attended Adverse Events (MAAEs) — 7; 6; 5; 7 Participants

Primary: Proportion of Patients Alive and Free of Respiratory Failure Through the 30-day Trial. — 100 Percentage of of patients alive and free

Primary: Anxiety: Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety 4a v1.0 — 56.9; 58.8 T-score